Stonepine Capital Management, LLC Royalty Pharma PLC Transaction History
Stonepine Capital Management, LLC
- $124 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
428Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.28 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$745 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$549 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$457 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...